Spironolactone (New indication) -- Adults
Drug information
Section 12: Cardiovascular medicines 12.4: Medicines used in heart failure
Formulation:
Application prepared by:
Marcus M. Reidenberg, M.D., Professor of Pharmacology, Medicine and Public Health, NewYork, NY
-
An application to recommend that aldosterone antagonists be added to the WHO Model List of Essential Medicines for heart failure (12.4) and that the representative of the aldosterone antagonist class be spironolactone
pdf, 367kb - EXPERT REVIEWS
-
Support from Coordinator, CPM/WHO
pdf, 38kb -
Support from Mount Sinai Heart
pdf, 253kb -
Support from the Centre for Chronic Disease Control
pdf, 73kb -
Comments from Médecins Sans Frontières
pdf, 282kb